IPA Stock Summary and Trading Ideas (Immunoprecise Antibodies Ltd. | NASDAQ:IPA)

ImmunoPrecise Antibodies Ltd is a biotechnology company that leverages multi-omics modeling and complex artificial intelligence through a series proprietary and patented technologies. The company owns an integrated end-to-end suite of capabilities to support the development of therapeutic antibodies and are known for solving very complex industry challenges.

Immunoprecise Antibodies Ltd. trades on the NASDAQ stock market under the symbol IPA.

As of March 4, 2025, IPA stock price climbed to $0.35 with 1,369,484 million shares trading.

IPA has a beta of 2.06, meaning it tends to be more sensitive to market movements. IPA has a correlation of 0.08 to the broad based SPY ETF.

IPA has a market cap of $16.14 million. This is considered a Sub-Micro Cap stock.

Last quarter Immunoprecise Antibodies Ltd. reported $4 million in Revenue and -$.07 earnings per share. This fell short of revenue expectation by $-624,000 and missed earnings estimates by -$.02.

In the last 3 years, IPA traded as high as $6.50 and as low as $.27.

IPA has underperformed the market in the last year with a price return of -80.1% while the SPY ETF gained +14.0%. However, in the short term, IPA had mixed performance relative to the market. It has outperformed in the last 3 months, returning -4.0% vs -4.7% return in SPY. But in the last 2 weeks, IPA shares have been beat by the market, returning -18.2% compared to an SPY return of -5.7%.

IPA support price is $.30 and resistance is $.36 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that IPA shares will trade within this expected range on the day.